130 related articles for article (PubMed ID: 24499434)
1. Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?
Karakurt DG; Demirsoy U; Corapcioglu F; Oncel S; Karadogan M; Arisoy ES
Pediatr Hematol Oncol; 2014 Aug; 31(5):415-24. PubMed ID: 24499434
[TBL] [Abstract][Full Text] [Related]
2. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
Corapcioglu F; Sarper N; Zengin E
Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
[TBL] [Abstract][Full Text] [Related]
3. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
[TBL] [Abstract][Full Text] [Related]
4. Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Karaman S; Vural S; Yildirmak Y; Emecen M; Erdem E; Kebudi R
Pediatr Blood Cancer; 2012 Apr; 58(4):579-83. PubMed ID: 21674768
[TBL] [Abstract][Full Text] [Related]
5. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Rizal AM; Nordiah AJ; Jamal R
Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
Viscoli C; Cometta A; Kern WV; Bock R; Paesmans M; Crokaert F; Glauser MP; Calandra T;
Clin Microbiol Infect; 2006 Mar; 12(3):212-6. PubMed ID: 16451406
[TBL] [Abstract][Full Text] [Related]
7. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
Fouyssac F; Salmon A; Mansuy L; Schmitt C; Bordigoni P; Chastagner P
Med Mal Infect; 2005 Jun; 35(6):357-62. PubMed ID: 15982848
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.
Cies JJ; Jain J; Kuti JL
Pediatr Blood Cancer; 2015 Mar; 62(3):477-82. PubMed ID: 25328131
[TBL] [Abstract][Full Text] [Related]
12. Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.
Simon A; Gröger N; Wilkesmann A; Hasan C; Wiszniewsky G; Engelhart S; Kramer MH; Bode U; Ammann RA; Fleischhack G
Int J Antimicrob Agents; 2006 Nov; 28(5):417-22. PubMed ID: 17046210
[TBL] [Abstract][Full Text] [Related]
13. Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Ichikawa M; Suzuki D; Ohshima J; Cho Y; Kaneda M; Iguchi A; Ariga T
Pediatr Blood Cancer; 2011 Dec; 57(7):1159-62. PubMed ID: 21438131
[TBL] [Abstract][Full Text] [Related]
14. Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study.
Uygun V; Karasu GT; Ogunc D; Yesilipek A; Hazar V
Pediatr Blood Cancer; 2009 Oct; 53(4):610-4. PubMed ID: 19484759
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
Sato T; Kobayashi R; Yasuda K; Kaneda M; Iguchi A; Kobayashi K
Pediatr Blood Cancer; 2008 Dec; 51(6):774-7. PubMed ID: 18661495
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
Demirkaya M; Celebi S; Sevinir B; Hacımustafaoglu M
Pediatr Hematol Oncol; 2013 Mar; 30(2):141-8. PubMed ID: 23301757
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
Zengin E; Sarper N; Kılıç SC
Pediatr Hematol Oncol; 2011 May; 28(4):311-20. PubMed ID: 21524156
[TBL] [Abstract][Full Text] [Related]
18. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
19. Imipenem versus piperacillin/tazobactam for empiric treatment of neutropenic fever in adults.
Roohullah A; Moniwa A; Wood C; Humble M; Balm M; Carter J; Weinkove R
Intern Med J; 2013 Oct; 43(10):1151-4. PubMed ID: 23800137
[TBL] [Abstract][Full Text] [Related]
20. Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.
Le Guyader N; Auvrignon A; Vu-Thien H; Portier E; Tabone MD; Leverger G
Support Care Cancer; 2004 Oct; 12(10):720-4. PubMed ID: 15138864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
